Global Intravenous (IV) Disinfecting Caps Market to reach USD XX billion by 2027.Global Intravenous (IV) Disinfecting Caps Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Intravenous (IV) Disinfecting Caps acts as a source of Continuous passive disinfection and prevents contamination and bloodstream infection. Disinfecting IV caps contain an antiseptic barrier that provides continuous disinfection. Growing prevalence of chronic disease and rising disorders that lead to surgery are key drivers for the growth of Intravenous (IV) Disinfecting Caps market. According to an article from United Nations (UN) by the year 2030, the proportion of total global deaths due to chronic diseases is estimated to increase to 70 per cent and the global burden of disease is expected to increase to 56 per cent. The greatest increase is projected in the African and Eastern Mediterranean regions. Also, according to American Cancer Society by 2040, new cancer cases are expected to grow to 27.5 million globally from 17.0 million in 2018 and cancer deaths to reach to 16.3 million from 9.5 million in 2018. This rise would be primarily due to the growth and aging of the population. Also, with the increasing precautions and sanitization measures and rising need for Parenteral nutrition aids, the adoption & demand for Intravenous (IV) Disinfecting Caps is likely to increase the market growth during the forecast period. However, supply chain disruption of Intravenous (IV) Disinfecting Caps due to covid 19 pandemic impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Intravenous (IV) Disinfecting Caps market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rising R&D and technological advancement in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027. Factors such rising incidence of healthcare-associated diseases and growing awareness for sanitization in the region would create lucrative growth prospects for the Intravenous (IV) Disinfecting Caps market across Asia-Pacific region.

Major market player included in this report are:
Kisico
Phenomenome Discoveries Inc.

Human Metabolome Technologies, Inc.

Thermo Fisher Scientific, Inc.,

Bio- Rad Laboratories, Inc.

Biocrates Life Sciences AG

Agilent Technologies, Inc

Merit Medical

BD

3M
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Single Cap
Double Cap
By Application:
Blood Collection,
Blood Transfusion,
Infusion,
Others
By Distribution Channel:
Retail Distributors
Non-Retail Distributors

By End-user:
Hospitals,
Clinics,
Diagnostic Centre,
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Intravenous (IV) Disinfecting Caps Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors